Traumatic Brain Injury Screening in Outpatient Neurology
GIA® screens during rooming or in the waiting area before the neurologist enters — capturing structured cognitive, motor-speech, and behavioral biomarker data that the specialist reviews alongside the patient's history and exam. The 40-second conversation produces results in under two minutes, available in the EHR before the face-to-face portion of the visit begins.
Traumatic brain injury is a leading cause of injury-related death and disability in the United States. The CDC reports 68,663 TBI-related deaths in 2023 — approximately 190 per day — and approximately 2.5 million TBI-related emergency department visits annually (CDC Surveillance Report of Traumatic Brain Injury-related Emergency Department Visits, Hospitalizations, and Deaths, United States, 2014). An estimated 5.3 million Americans live with a permanent TBI-related disability. Detection of mild TBI in routine clinical practice is poor: a prospective cohort study at a Level I trauma center and an academic ED found that 56% of patients meeting CDC mild TBI criteria did not have a documented mild TBI-related diagnosis in the ED record — the greatest physician-versus-research-personnel discrepancy was for confusion (94% identified by research vs 28% documented by ED physician) (Powell, Ferraro, Dikmen, Temkin, Bell, Archives of Physical Medicine and Rehabilitation 2008). Voice and speech changes — dysarthria, prosodic flattening, articulation rate change, and word-finding latency — are well-documented sequelae of TBI across severity levels and persist into post-acute and chronic phases. Peer-reviewed speech biomarker research underlying GIA® reports AUC 0.962 for traumatic brain injury detection from natural conversation (Sensitivity 0.896, Specificity 0.891, Accuracy 0.894).
Outpatient neurology evaluates and manages cognitive, movement, and neurodegenerative disorders referred from primary care or self-referred. Among Medicare patients referred for neurology evaluation, the average wait to first appointment is 34 days, and 18% wait longer than 90 days (AAN study, Neurology, 2025). The underlying peer-reviewed speech biomarker research reports AUC 0.97 for Parkinson's disease detection from natural conversation (Sensitivity 0.98, Specificity 0.96). GIA® delivers that structured speech-biomarker data during the encounter itself — available in the EHR before the neurologist begins the face-to-face portion of the visit.
Why Traumatic Brain Injury goes undetected in outpatient neurology
A neurologist or neurology nurse practitioner conducts the patient encounter. Support staff (medical assistants or clinical staff) handle intake and vitals. Comprehensive cognitive and neurological screening competes with the chief complaint, history, exam, and care planning within the visit length. Traumatic Brain Injury symptoms are often subtle, progressive, and easily attributed to other factors in this care environment.
Among Medicare patients referred for neurology evaluation, 18% wait longer than 90 days for their first appointment (average wait: 34 days; AAN study, Neurology, 2025) — primary-care referrers operate without longitudinal data on the referred patient until the visit occurs
New-patient outpatient neurology visits run 45-59 minutes (CPT 99204) or 60-74 minutes (CPT 99205); history-taking, neurological and cognitive exam, differential diagnosis, care planning, and patient education compete for the same time window
Established-patient follow-up visits at 30-39 minutes (CPT 99214) or 40-54 minutes (CPT 99215) at a 3, 6, or 12-month cadence miss interval cognitive or motor-speech changes that would inform medication titration or care-plan decisions
Formal neuropsychological testing (CPT 96132 first hour + 96133 each additional hour) is administered in a separate extended-time encounter when comprehensive cognitive characterization is warranted — adding to total time-to-evaluation across the diagnostic pathway
How does GIA® screen for Traumatic Brain Injury in outpatient neurology?
GIA® meets the patient by video, voice, or landline — wherever they are in the outpatient neurology environment. The screening conversation takes 40 seconds and feels like a natural check-in, not a clinical assessment.
During the conversation, GIA® analyzes over 2,500 speech biomarkers — including vocal tremor, articulatory precision, prosodic patterns, and cognitive load indicators — alongside 436 visual data points from facial micro-expressions and body movement during video sessions.
Results are delivered to the clinician in under 2 minutes. Four data types write back to the EHR automatically: structured screening results with ICD-10 codes, clinician-ready medical notes, a full timestamped transcript, and the recorded patient video. The clinician reviews and submits — the human is always in the loop.
Traumatic Brain Injury in outpatient neurology: the numbers.
The screening challenge
A new-patient neurology evaluation must combine history, neurological and cognitive exam, differential diagnosis, care planning, and patient education within 45-59 minutes (CPT 99204) or 60-74 minutes (CPT 99205). Formal neuropsychological testing (CPT 96132 first hour + 96133 each additional hour) is administered in a separate extended-time encounter when comprehensive cognitive characterization is warranted — it is not part of the new-patient encounter. Between scheduled visits, the specialist depends on patient self-report or primary-care follow-up, losing interval signal on progression that would inform medication titration or care-plan decisions. GIA® supplies structured cognitive and motor-speech biomarker data without consuming clinician visit time. Documentation supports billing accuracy for E/M coding; coding decisions remain with the clinical documentation and coding team.
What compliance requirements does this address?
E/M visit coding for outpatient services: CPT 99204 (45-59 min) / 99205 (60-74 min) for new patients; CPT 99214 (30-39 min) / 99215 (40-54 min) for established patients (AMA CPT 2026; CMS MLN006764). CPT 96132 (first hour) and 96133 (each additional hour) cover neuropsychological testing evaluation services when comprehensive cognitive characterization is clinically indicated. Documentation supports billing accuracy and the documented level of medical decision-making; coding decisions remain with the clinical documentation and coding team.
GIA® produces structured documentation automatically — screening results with ICD-10 codes, clinician-ready medical notes, full timestamped transcripts, and recorded patient video — all written back to the EHR in real time and available for clinical, billing, and compliance review.
Traumatic Brain Injury screening in outpatient neurology
How is Traumatic Brain Injury screened in outpatient neurology?
GIA® screens for Traumatic Brain Injury through a single conversational interaction lasting 40 seconds. She analyzes over 2,500 speech biomarkers using Voice AI, Computer Vision, and Speech Biomarkers. GIA® screens during rooming or in the waiting area before the neurologist enters — capturing structured cognitive, motor-speech, and behavioral biomarker data that the specialist reviews alongside the patient's history and exam. The 40-second conversation produces results in under two minutes, available in the EHR before the face-to-face portion of the visit begins. Results are delivered to the clinician in under 2 minutes.
Does Traumatic Brain Injury screening require additional staff?
No. GIA® conducts the screening conversation independently — zero additional clinical staff required during the interaction. A neurologist or neurology nurse practitioner conducts the patient encounter. Support staff (medical assistants or clinical staff) handle intake and vitals. Comprehensive cognitive and neurological screening competes with the chief complaint, history, exam, and care planning within the visit length. The clinician reviews the results in under 2 minutes.
What is the accuracy of Traumatic Brain Injury screening?
Traumatic Brain Injury screening accuracy: AUC 0.962. The platform is peer-reviewed across 19 published studies and trained on 12.3 million longitudinal PAC/LTC patient records and 27 billion clinical events.
How does GIA® fit into the neurology visit workflow?
GIA® screens during rooming or in the waiting area before the neurologist enters. The 40-second conversation produces structured cognitive, motor-speech, and behavioral biomarker results in under two minutes — available in the EHR for the neurologist to review alongside the patient's history and exam during the face-to-face encounter.
How does GIA® support documentation for outpatient E/M coding (99204 / 99205 / 99214 / 99215)?
GIA® writes structured screening results with ICD-10 codes, clinician-ready medical notes, a full timestamped transcript, and the recorded patient video back to the EHR in real time. That documentation contributes to the level of medical decision-making documented in support of E/M coding (99204 / 99205 for new patients; 99214 / 99215 for established patients). Documentation supports billing accuracy; coding decisions remain with the clinical documentation and coding team.
Can GIA® be used between scheduled neurology visits to monitor progression?
Yes. GIA® can be administered by phone, landline, or video between scheduled visits — capturing interval changes in speech biomarkers that signal cognitive or motor-speech progression. Results write back to the EHR for clinician review at the next visit, or asynchronously if the change is clinically significant.
How does GIA® relate to formal neuropsychological testing (CPT 96132 / 96133)?
GIA® is a screening tool, not a neuropsychological battery. It surfaces structured risk signals from speech and behavioral biomarkers in 40 seconds. Formal neuropsychological evaluation (CPT 96132 first hour + 96133 each additional hour) remains the appropriate next step when GIA® or other screening evidence warrants comprehensive cognitive characterization. The clinician determines when formal testing is indicated.
How does GIA® screen for traumatic brain injury?
GIA® analyzes 2,500+ speech biomarkers — including articulation rate, vocal stability, prosodic patterns, processing speed, and word-finding markers associated with TBI sequelae — from a natural conversation lasting 40 seconds. Peer-reviewed biomarker accuracy reports AUC 0.962 (Sensitivity 0.896, Specificity 0.891) for TBI detection. Results write back to the EHR with structured notes for clinician review. A clinician reviews and approves every result before it enters the clinical record.
Why is mild TBI underdetected in clinical practice?
A 2008 prospective study (Powell, Ferraro, Dikmen, Temkin, Bell, Archives of Physical Medicine and Rehabilitation) found that 56% of patients meeting CDC mild TBI criteria at a Level I trauma center and academic ED did not have a documented mild TBI-related diagnosis in the ED record. The largest discrepancy between research-personnel identification and ED-physician documentation was for confusion (94% vs 28%). Standard sideline and acute tools (SAC, ImPACT, BESS) are designed for specific contexts; longitudinal post-acute speech and cognitive change is rarely structured outside specialty TBI programs.
Why are speech biomarkers relevant to TBI detection?
TBI produces well-documented changes across motor speech (dysarthria, articulation rate, vocal stability), prosody, processing speed, and word-finding latency. These changes persist into post-acute and chronic phases and can be measured from natural conversation without requiring a structured clinical instrument. Peer-reviewed speech biomarker research underlying GIA® reports AUC 0.962 (Sensitivity 0.896, Specificity 0.891) for TBI detection.
Does GIA® diagnose traumatic brain injury?
No. GIA® screens — she does not diagnose. She surfaces structured risk signals from speech biomarker analysis for clinician review. The clinician applies clinical judgment, reviews additional data (mechanism of injury, neurological examination, neuroimaging where indicated, GCS, post-injury timeline, symptom inventory), and makes any diagnostic determination, including severity classification. GIA® is a clinical decision support tool with mandatory clinician-in-the-loop review on every result.
How does GIA® fit into TBI follow-up and longitudinal tracking?
GIA® can be administered by phone, landline, or video between scheduled follow-up visits — capturing interval changes in speech biomarkers that signal recovery trajectory, persistent symptoms, or progression. Results write back to the EHR for clinician review at the next visit, or asynchronously if change is clinically significant. The 40-second screening is operationally compatible with the new-patient neurology evaluation envelope (CPT 99204 / 99205) and post-acute care plan workflows.
Traumatic Brain Injury screening in other care settings
Other conditions screened in outpatient neurology
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.
See GIA® screen for Traumatic Brain Injury live
40 seconds. 60-second results. Zero staff time.